sacituzumab govitecan
gilead sciences
['bcsm', 'mbc', ' sg ', 'tropics02']
tropics02 - sg vs chemotherapy in pretreated (2-4 prior lines) hr+/her2- mbc. sg led to an increase in pfs of 4 vs 5.5 months, orr was 14% vs 21%, longer follow up is needed for os #bcsm #asco22 
Breast medical oncologist @TuftsMedicalCtr | Tweets are my own | ???? ????